HIV Research & Clinical Practice, Volume 15, Issue 5 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

HIV Clinical Trials, Volume 15, Issue 5 (2014)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Volume 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Original Articles

Article
The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials
Eric Ross, Frank Tanser, Pamela Pei, Marie-Louise Newell, Elena Losina, Rodolphe Thiebaut, Milton Weinstein, Kenneth Freedberg, Xavier Anglaret, Callie Scott, Francois Dabis & Rochelle Walensky
Pages: 185-198
Published online: 22 Dec 2014
AbstractforThe Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials | References | PDF (416.4 KB)
  • 62 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients
L. Curtis, G. Nichols, C. Stainsby, J. Lim, A. Aylott, B. Wynne, A. Clark, M Bloch, G. Maechler, L.. Martin-Carpenter, F. Raffi & S. Min
Pages: 199-208
Published online: 22 Dec 2014
AbstractforDolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients | References | PDF (541.7 KB)
  • 620 Views
  • 36 CrossRef citations
  • 0Altmetric
Free Access
Article
Efficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B Trial
Edwin DeJesus, Gerd Fätkenheuer, Catherine Orrell, Cunshan Wang, James Jones, Charles Craig, Margaret Tawadrous & Jayvant Heera
Pages: 209-217
Published online: 22 Dec 2014
AbstractforEfficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B Trial | References | PDF (513.2 KB)
  • 106 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients
Rima Kulkarni, Michael E. Abram, Damian J. McColl, Tiffany Barnes, Marshall W. Fordyce, Javier Szwarcberg, Andrew K. Cheng, Michael D. Miller & Kirsten L. White
Pages: 218-230
Published online: 22 Dec 2014
AbstractforWeek 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients | References | PDF (205.2 KB)
  • 358 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access

Research Article

Article
The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials
Pages: 231-244
Published online: 22 Dec 2014
First Page PreviewforThe Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials | References | PDF (420.4 KB)
  • 23 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles